NeuroMetrix Revenue and Competitors

Boston, MA USA

Location

$105.2M

Total Funding

Estimated Revenue & Valuation

  • NeuroMetrix's estimated annual revenue is currently $15M per year.(i)
  • NeuroMetrix's estimated revenue per employee is $230,769
  • NeuroMetrix's total funding is $105.2M.

Employee Data

  • NeuroMetrix has 65 Employees.(i)
  • NeuroMetrix grew their employee count by 8% last year.

NeuroMetrix's People

NameTitleEmail/Phone
1
Chief Data ScientistReveal Email/Phone
2
ControllerReveal Email/Phone
3
VP Clinical PartnershipsReveal Email/Phone
4
SVP, CFOReveal Email/Phone
5
Director, Partner SuccessReveal Email/Phone
6
Senior Director MarketingReveal Email/Phone
7
Director, Partner SuccessReveal Email/Phone
8
Director Sales, NeuromodulationReveal Email/Phone
9
Director Product DevelopmentReveal Email/Phone
10
Credit & Collection ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.8M393%N/AN/A
#2
$8.5M343%N/AN/A
#3
$3M12-29%N/AN/A
#4
$5630M7477-11%$450MN/A
#5
$4.5M186%N/AN/A
#6
$7.2M5727%$29.6MN/A
#7
$14.3M57-12%N/AN/A
#8
$2.3M186%$44MN/A
#9
$40.7M162-1%N/AN/A
#10
$45.7M182-5%N/AN/A
Add Company

What Is NeuroMetrix?

NeuroMetrix, Inc., located in Waltham, MA, is a spin-off from the Harvard-M.I.T. Division of Health Sciences and Technology. Based on advances in neuroscience and microelectronics, NeuroMetrix is developing a new class of non-invasive products for point-of-care testing of neuromuscular disorders. The Company\'s technology provides physicians with immediate and cost-effective information to be used as an aid in the diagnosis of common neuromuscular conditions such as carpal tunnel syndrome, low back pain, and diabetes related nerve disease.

keywords:N/A

$105.2M

Total Funding

65

Number of Employees

$15M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

NeuroMetrix News

2022-04-19 - NeuroMetrix - Patient Perspective, A conversation with Alison Maguire, Head of Research & Finance, The Lily Foundation

NeuroMetrix - Patient Perspective, A conversation with Alison Maguire, Head of Research & Finance, The Lily Foundation ... WOBURN, Mass. -...

2022-04-17 - NEUROMETRIX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)

NEUROMETRIX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q). Link copied.

2022-04-17 - NeuroMetrix Reports Q1 2022 Financial Results

WOBURN, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the...

2017-10-31 - NeuroMetrix Closes $3.5 Million Equity Offering

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO) today closed a $3.5 million private placement of 3,500 shares of Series F convertible preferred stock at a price of $1,000 per share that are convertible into 1,330,798 shares of common stock at a conversion price of $2.63 per sha ...

2016-06-08 - NeuroMetrix Raises $21.3 Million

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) reported that it has closed its previously announced private placement of preferred stock and warrants. The Company sold to a healthcare dedicated institutional investor 21,300 shares of Series D convertible preferred stock at a p ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.4M65-21%N/A
#2
$35M6610%N/A
#3
$17.2M6620%N/A
#4
$8.9M6810%N/A
#5
$10.5M68-3%N/A